We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCS
2276
DELISTED
Steelcase
SCS
$26K ﹤0.01%
+1,955
New +$27.7K
TSQ icon
2277
Townsquare Media
TSQ
$118M
$26K ﹤0.01%
4,017
-11,191
-74% -$78.9K
TWI icon
2278
Titan International
TWI
$475M
$26K ﹤0.01%
2,383
-3,047
-56% -$35.3K
HALL
2279
DELISTED
Hallmark Financial Services, Inc.
HALL
$26K ﹤0.01%
258
+160
+163% +$15.8K
XEC
2280
DELISTED
CIMAREX ENERGY CO
XEC
$26K ﹤0.01%
254
-887
-78% -$84.2K
PFBI
2281
DELISTED
Premier Financial Bancorp
PFBI
$26K ﹤0.01%
1,410
+1,160
+464% +$20K
ISCA
2282
DELISTED
International Speedway Corp
ISCA
$26K ﹤0.01%
582
-1,053
-64% -$44.5K
SFLY
2283
DELISTED
Shutterfly, Inc.
SFLY
$26K ﹤0.01%
287
-5,141
-95% -$462K
WRD
2284
DELISTED
WildHorse Resource Development
WRD
$26K ﹤0.01%
+1,017
New +$25.4K
EEP
2285
DELISTED
Enbridge Energy Partners
EEP
$26K ﹤0.01%
+2,343
New +$23.4K
LPNT
2286
DELISTED
LifePoint Health, Inc.
LPNT
$26K ﹤0.01%
545
-687
-56% -$35.6K
AES icon
2287
AES
AES
$10.5B
$25K ﹤0.01%
+1,876
New +$23.1K
ASPS icon
2288
Altisource Portfolio Solutions
ASPS
$65.8M
$25K ﹤0.01%
+109
New +$24.9K
BIT icon
2289
BlackRock Multi-Sector Income Trust
BIT
$702M
$25K ﹤0.01%
1,466
+866
+144% +$14.8K
CCO icon
2290
Clear Channel Outdoor Holdings
CCO
$1.23B
$25K ﹤0.01%
5,920
-110
-2% -$515
CIVB icon
2291
Civista Bancshares
CIVB
$589M
$25K ﹤0.01%
1,021
+545
+114% +$13K
CORT icon
2292
Corcept Therapeutics
CORT
$12B
$25K ﹤0.01%
1,575
+1,042
+195% +$18.1K
CRBP icon
2293
Corbus Pharmaceuticals
CRBP
$188M
$25K ﹤0.01%
+162
New +$29.4K
DBJP icon
2294
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$705M
$25K ﹤0.01%
+598
New +$25.8K
DK icon
2295
Delek US
DK
$3.58B
$25K ﹤0.01%
+500
New +$24.9K
DPG
2296
Duff & Phelps Utility and Infrastructure Fund
DPG
$524M
$25K ﹤0.01%
+1,761
New +$25.1K
FND icon
2297
Floor & Decor
FND
$6.68B
$25K ﹤0.01%
+498
New +$25.6K
LAB icon
2298
Standard BioTools
LAB
$314M
$25K ﹤0.01%
4,133
-12,817
-76% -$73K
MIDD icon
2299
Middleby
MIDD
$6.08B
$25K ﹤0.01%
240
-1,418
-86% -$161K
MPAA icon
2300
Motorcar Parts of America
MPAA
$258M
$25K ﹤0.01%
1,361
-4,353
-76% -$90.8K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.